Reviewed by Julian Douwes M.D., Chief Medical Officer, Klinik St. Georg
Joint pain is one of the hallmark symptoms of Lyme disease — and one of the most commonly misdiagnosed. If your joint pain moves from one location to another, fluctuates unpredictably, and does not respond to standard arthritis treatment, there may be an infectious explanation that has been overlooked.
What it is: Inflammatory joint pain caused by the immune response to Borrelia burgdorferi, ranging from intermittent joint aching to severe Lyme arthritis with visible swelling and reduced range of motion.
How common: Joint symptoms affect an estimated 60% of untreated Lyme patients and are the primary symptom in many cases of late-stage Lyme disease. The knee is the most frequently affected joint.
Distinguishing feature: Unlike osteoarthritis or rheumatoid arthritis, Lyme joint pain is characteristically migratory — it shifts between joints, often asymmetrically, and fluctuates in intensity over days or weeks.
Lyme-associated joint pain takes several forms, and patients often experience more than one pattern simultaneously:
The most commonly affected joints are the large joints — particularly the knees, which are involved in roughly 80% of Lyme arthritis cases. Shoulders, ankles, elbows, wrists, hips, and the temporomandibular joint (jaw) can also be affected.
Published research
Lyme arthritis is one of the most well-studied manifestations of Lyme disease. The mechanisms are complex and involve both direct infectious and autoimmune components:
Direct synovial infection. Borrelia burgdorferi has a documented affinity for joint tissue. The spirochete can invade the synovial membrane — the tissue lining the joint cavity — where it triggers a localized inflammatory response. Borrelia DNA has been detected in synovial fluid of patients with Lyme arthritis, confirming direct joint involvement.
Immune-mediated inflammation. The immune system responds to the presence of bacteria in the joint by deploying inflammatory cells and cytokines. This inflammatory cascade causes the swelling, warmth, pain, and stiffness characteristic of Lyme arthritis. In some patients, this immune response can become self-perpetuating.
Antibiotic-refractory Lyme arthritis. In a subset of patients — estimated at 10-20% of those with Lyme arthritis — joint inflammation persists even after antibiotic treatment. Research suggests this may involve autoimmune mechanisms, in which the immune system continues attacking joint tissue after the infection has been addressed, potentially due to molecular mimicry between bacterial proteins and human joint proteins.
Biofilm and persistence. There is growing research interest in the ability of Borrelia to form biofilm-like structures and persist in tissue niches, including joints. These forms may be less susceptible to standard antibiotic treatment, potentially explaining why some patients experience recurring joint symptoms.
Because joint pain is such a common complaint, Lyme arthritis is frequently confused with other conditions. Key distinguishing features include:
One of the most frustrating aspects of Lyme joint pain is its unpredictability. Patients describe a cycle:
This waxing-and-waning pattern is characteristic of Lyme disease and reflects the cyclical nature of the immune response to the infection. It can lead to delays in diagnosis, as physicians may evaluate the patient during a quiescent period when examination findings are unremarkable.
Clinical experience
Treating Lyme arthritis effectively requires addressing both the infectious trigger and the inflammatory response. Approaches include:
Whole-body hyperthermia. Hyperthermia targets the underlying infection by raising core body temperature to levels at which Borrelia becomes structurally unstable. For patients with Lyme arthritis, reducing the infectious burden can quiet the inflammatory cascade driving joint symptoms. In our clinical experience, joint pain and swelling are among the symptoms that frequently improve following hyperthermia-based treatment.
Antimicrobial protocols. Targeted antibiotics remain a cornerstone of Lyme arthritis treatment. Protocols may include agents with good joint tissue penetration and extended courses for persistent cases.
Anti-inflammatory support. While the underlying infection is being addressed, supportive anti-inflammatory therapies can help manage acute pain and reduce the inflammatory burden on affected joints.
Immune modulation. For patients with antibiotic-refractory Lyme arthritis, therapies aimed at calming the autoimmune component of joint inflammation may be incorporated into the treatment program.
Recovery patterns vary. Some patients experience rapid improvement in joint symptoms during or shortly after treatment. Others, particularly those with long-standing antibiotic-refractory arthritis, may improve more gradually as the immune dysregulation resolves over weeks to months.
Our symptom assessment helps you understand whether your symptoms align with common Lyme disease patterns. It takes about 3 minutes and is not a diagnosis.
Check your symptomsJoint pain rarely occurs in isolation. Patients experiencing Lyme arthritis frequently also report:
Neuropathic symptoms including tingling, numbness, and burning sensations — signs of peripheral nervous system involvement that often accompany joint symptoms.
Persistent, debilitating exhaustion that does not improve with rest — compounded by the physical toll of ongoing joint inflammation and pain.
Cognitive dysfunction affecting concentration, memory, and mental clarity — reflecting the same neuroinflammatory processes that drive Lyme arthritis.
A case review is a no-commitment first step. Our medical team will assess whether your symptoms may benefit from advanced treatment.
Request a case review